TLR agonists
    4.
    发明授权
    TLR agonists 有权
    TLR激动剂

    公开(公告)号:US09359360B2

    公开(公告)日:2016-06-07

    申请号:US13682208

    申请日:2012-11-20

    申请人: Suzanne Grimshaw

    摘要: The present invention provides for TLR agonist conjugates (compounds) and compositions, as well as methods of using them. The compounds of the invention are broad-spectrum, long-lasting, and non-toxic combination of synthetic immunostimulatory agents, which are useful for activating the immune system of a mammal, preferably a human and can help direct the pharmacophore to the receptor within the endosomes of target cells and enhance the signal transduction induced by the pharmacophore.

    摘要翻译: 本发明提供了TLR激动剂缀合物(化合物)和组合物,以及使用它们的方法。 本发明的化合物是合成免疫刺激剂的广谱,持久和无毒组合,其可用于激活哺乳动物,优选人的免疫系统,并且可以帮助将药效团引导至受体内的受体 靶细胞的内体,并增强由药效团诱导的信号转导。